July 25, 2021
3 min watch
Save
VIDEO: Waring discusses phase 3 results for presbyopia drop
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Practice Management in Psychiatry.
Added to email alerts
You've successfully added Practice Management in Psychiatry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Practice Management in Psychiatry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — In this video perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses phase 3 data from the GEMINI 1 study investigating AGN-190584 (pilocarpine 1.25%, Allergan) for the treatment of presbyopia.
Published by:
Sources/Disclosures
Collapse
Source:
George O. Waring IV, MD, FACS
Read more from American Society of Cataract and Refractive Surgery Meeting
View allApril 09, 2025
2 min read
Save
June 06, 2024
1 min read
Save
May 03, 2024
3 min watch
Save
April 30, 2024
4 min watch
Save
April 25, 2024
1 min watch
Save
April 22, 2024
1 min read
Save
April 22, 2024
3 min watch
Save
April 22, 2024
4 min watch
Save
April 20, 2024
2 min watch
Save
Read more about
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Practice Management in Psychiatry.
Added to email alerts
You've successfully added Practice Management in Psychiatry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Practice Management in Psychiatry to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.